Our leadership team brings together the unique talents of world-leading physicians and scientists. We have dedicated years of research to developing safe, non-invasive alternatives to traditional testing methods. We all share the same vision to empower patients and clinicians through a greater understanding of liver disease, and we aim to create a culture of patient-centric innovation throughout the organization.

Interim CEO

Dr Rexford Newbould

Chief Strategy Officer

Dr Keri Hildick

Chief Technical Officer

Dr Matthew Robson

President Pharma Solutions

Marija Mavar

VP People Success

Mehru Asad

SVP Investor Relations

Amanda Chin

VP Operations

Andrea Borghetto